Skip to main content
Veterinary Medicine and Science logoLink to Veterinary Medicine and Science
. 2026 Jun 29;12(4):e71042. doi: 10.1002/vms3.71042

Cryptosporidium spp. infections in Tunisia: Epidemiology and public health implications

Faten Bouaicha 1, Aurélie Chevillot 1, Sihem El Hamdi Mansour 2, Bruno Polack 1, Maxime Delsart 3, Karim Tarik Adjou 1
PMCID: PMC13312975  PMID: 42371675

ABSTRACT

Background

Cryptosporidiosis is an emerging worldwide zoonosis caused by an opportunistic protozoon, Cryptosporidium spp. In Tunisia, the lack of knowledge on the occurrence and genetic characteristics of Cryptosporidium spp. limits the understanding of its epidemiology, impact and transmission routes.

Objectives

The present review aims to collect, compile and summarise data on the prevalence of Cryptosporidium spp. infections in humans, animals and the environment contamination in Tunisia.

Methods

A systematic review was conducted across international databases using PRISMA 2020 Guidelines. Data from 15 selected studies were extracted and organised into thematic categories, including prevalence rates, risk factors, diagnostic methods, and population groups affected. A qualitative synthesis approach was used to analyse and compare findings across studies, highlighting trends, gaps, and public health implications.

Results

The publications indicate that Cryptosporidium spp. infections are prevalent in both humans and animals, but the results remain confusing and may not reflect the real impact of the disease. In animals, only three studies were conducted in livestock and poultry. Only Cryptosporidium parvum (IIa and IId) was identified in the three studies from adult asymptomatic animals. Therefore, this finding may not reveal the true impact of the parasite on animal health. In humans, all studies were conducted in hospitals on adult and child patients diagnosed with either cancer or immunodeficiency. Cryptosporidium parvum and Cryptosporidium hominis were by far the predominant species suggesting potential zoonotic and anthroponotic transmission routes in humans. Of the two studies conducted on wastewater, five Cryptosporidium species (C. parvum, C. hominis, Cryptosporidium meleagridis, Cryptosporidium muris, Cryptosporidium andersoni, Cryptosporidium ubiquitum) and three genotypes were identified, highlighting the potential role of water as a potential route of Cryptosporidium spp. transmission.

Conclusions

The current review give an overview of the circulating Cryptosporidium spp. species and genotypes but they remain insufficient to fully understand the transmission dynamics, zoonotic potential and animal welfare implications of Cryptosporidium spp. in Tunisia.

Keywords: Cryptosporidium spp, epidemiology, molecular prevalence, Tunisia, zoonoses


Cryptosporidiosis, caused by Cryptosporidium spp., is a zoonotic disease affecting humans and animals worldwide. This review summarises available data on the prevalence and genetic diversity of Cryptosporidium spp. in Tunisia using published studies. Evidence indicates infections in humans, livestock, poultry, and wastewater, although data remain limited. Cryptosporidium parvum and Cryptosporidium hominis are the predominant species in humans, while only C. parvum has been identified in animals. Multiple species detected in wastewater highlight water as a potential transmission route, emphasising the need for further epidemiological studies.

graphic file with name VMS3-12-e71042-g003.jpg

1. Introduction

Cryptosporidium spp. are intracellular protozoan parasites that infect a wide range of vertebrate hosts, including humans, domestic animals, and wildlife (Ryan et al. 2021a). This protozoan parasite remains a global Public Health concern, having been established as a leading cause of diarrhoea‐associated death in children and immunocompromised individuals in many developing countries in which the protozoan parasite is endemic (Sow et al. 2016; Kotloff et al. 2019a). The Global Enteric Multicentre Study has shown that Cryptosporidium spp. are a major cause of moderate‐to‐severe diarrhoea and mortality in young children in African and Asian countries (Delahoy et al. 2018; Kotloff et al. 2019b; Levine et al. 2020). It is also a frequent cause of water‐borne, and food‐borne, outbreaks of infection in many industrialised nations (Efstratiou et al. 2017; Zahedi and Ryan 2020). The transmission of Cryptosporidium spp. is primarily via a fecal‐oral route, occurring through the ingestion of environmentally resistant oocysts present in contaminated water, food, or via direct contact with infected hosts. Accessory contamination can also occur through inhalation of oocysts (Sponseller et al. 2014 Jul). To date, about 47 species of Cryptosporidium and more than 120 genotypes have been identified (Ryan et al. 2021b; Zhao et al. 2023), including C. hominis and C. parvum, which represent the 95% of cryptosporidiosis cases in humans (Lebbad et al. 2021).

In Tunisia, cattle, sheep and goat farming are the primary source of local food production, mainly meat and milk. They are also the main source of revenue for livestock farmers. However, Tunisian livestock is affected by a variety of parasitic infections, such as gastrointestinal parasites (Rouatbi et al. 2020; Hammami et al. 2024) or tick‐borne parasites (Khamassi Khbou et al. 2021). Cryptosporidiosis in neonatal calves, lambs and goat kids remains poorly documented. Only a few studies have been conducted namely in neonatal calves where C. parvum has been reported with a prevalence as high as 86.7% in a dairy farm in the Sfax region (Soltane et al. 2007a). However, genotyping was not conducted in this early report, limiting further interpretation of its zoonotic potential.

Environmental studies remain scarce, though preliminary investigations suggest the presence of oocysts in surface and drinking water sources, raising concerns about waterborne transmission pathways.

This review aims to provide a comprehensive summary of the current state of knowledge regarding Cryptosporidium spp. infection in Tunisia, by focusing on its prevalence, species distribution, subtypes, and potential transmission dynamics across human, animal, and environmental interfaces. By critically analysing the available data, we seek to identify gaps in surveillance, molecular characterisation, and public health policy, thereby guiding future research and control strategies.

2. Materials and Methods

A comprehensive literature search was conducted across five databases, PubMed, Google Scholar, ResearchGate, ScienceDirect and Cabi, to identify relevant publications. Articles published in local journals were also used after a ResearchGate search.

The search strategy was based on the use of specific keywords and their combinations, including ‘Cryptosporidium’, ‘cryptosporidiosis’, and ‘Tunisia’, focusing on studies conducted in humans, animals, and on environmental samples in Tunisia (Figure 1).

FIGURE 1.

FIGURE 1

PRISMA diagram.

Therefore, using a PRISMA 2020 guidelines, only studies with an accessible full text that reported the detection, prevalence, and/or typing of Cryptosporidium spp. using molecular and/or microscopic methods in humans, animals, and environmental samples were included. Regional and systematic reviews were excluded.

A total of 15 peer‐reviewed research articles studying the infection by Cryptosporidium spp. in humans (n = 10) (Table 1), animals (n = 3) (Table 2) and detection in the environment (n = 2) (Table 3) were included in this review.

TABLE 1.

Human Cryptosporidium spp. infection prevalence reported in Tunisia.

Prevalence % (positive/examined samples)
District Study period Population Associated symptoms Matrix Diagnosis method Cryptosporidium spp. C. hominis C. meleagridis C. parvum subtype Reference
Bizerte April–October 2007 Children < 5 years (n = 403) Diarrhoea (n = 52) Fecal samples

MZN / rRNA 18S, GP60 RFLP

Sequencing

0.7% (3/403) 4/403 (0.09%)

IIaA15G2R1 (n = 2)

IIdA16G1 (n = 2)

(Rahmouni et al. 2014)
Tunis 2006–2009 Children with primary immunodeficiencies Chronic diarrhoea Fecal samples MZN, rRNA 18S, RFLP 3/5 1/5 1/5 NR (Ben Abda et al. 2011)
Tunisian hospitals 2010–2015

HIV + (n = 174)

Immunocompetent children (n = 260)

Myeloma (n = 54)

Immunocompromised children (n = 23)

Colorectal cancer (n = 15)

Diarrhoea or vomiting Fecal samples

Weber‐Green modified trichrome staining

PCR RFLP 18S rRNA, sequencing

8/174 (4.5%)

4/260 (1.5%)

3/54 (5.5%)

3/23 (13%)

2/15 (13.3%)

2/174 (1.1%)

0

0

0

0

12/174(6.8%)

3/260 (1.1%)

0

1/23 (4.3%)

3/15 (20%)

C. hominis

IaA26G1R1

C. parvum

IIaA14G2R1

IIaA15G2R1

IIaA16G2R1

IIaA20G1R1

IIdA15G2R1

IIdA16G2R1

IIdA19G2R1

C. meleagridis

IIIbA26G1R1

(Essid et al. 2018)
Tunis 2010–2015

HIV patients (n = 174)

Immunocompromised children (n = 23)

Adults with myeloma (n = 54)

Children < 5 years (n = 260)

Fecal samples PCR, RFLP, sequencing

8/174 (4.59%)

3/23 (13%)

3/54 (5.5%)

4/260 (1.5%)

C. hominis

IaA26G1

(Essid et al. 2017)
Tunis 2006–2014

Patients with colorectal cancer (n = 39)

Intestinal biopsies

PCR‐HRM

(DHFR gene)

0 0 5/39 (13%) NR (Jelassi et al. 2024)
Sousse 1991–2002

Immunocompetent children

(n = 34,020)

Diarrhoea Fecal samples MZN 180/34,020 (0.32%) (Fathallah et al. 2004)
Sfax 1997–2006

Children and adults

(n = 30,573)

Fecal samples MZN

17/30,573

(0.05%)

(Cheikhrouhou et al. 2009)

Abbreviations: HRM: high‐resolution melt; MZN: modified Ziehl‐Neelsen; NR: not reported.

TABLE 2.

Farm animal Cryptosporidium spp. infection prevalence reported in Tunisia.

Prevalence % (positive/examined sample)
District Study period Animal species Age Associated symptoms Diagnostics methods Cryptosporidium spp. C. hominis C. meleagridis C. parvum subtype Reference

Bizerte

Joumine

April–October 2007 Calves (n = 70) < 5 months Diarrhoea (n = 52)

MZN

18S nested PCR

RFLP

Gp60

Sequencing

21.4 (15/70)

IIaA15G2R1 (n = 13)

IIdA16G1 (n = 2)

(Rahmouni et al. 2014)
Sfax 2000 Calves (n = 30) < 1 month Diarrhoea

MZN

Nested PCR

Sequencing

86.7 (26/30) NR (Soltane et al. 2007a)

Tunis

Nabeul

Le Kef

Siliana

Sidi Bouzid

Kairouan

Médenine

2003–2004 Lambs (n = 30) < 3 months

MZN

Nested PCR

Sequencing

16.7 (5/30) NR (Soltane et al. 2007b)
Sheep (n = 59) > 1 year 8.5 (5/59)
Goats (n = 184) 1–7 years 0
Horses (n = 190) 1–3 years 0
Rabbits (n = 178) 1–2 months 0
Camels (n = 110) 3–8 months 0
Chickens (n = 200) 0–56 days (4.5) 9/200
Turkeys (n = 50) NR 0

Abbreviations: MZN: modified Ziehl‐Neelsen; NR: not reported.

TABLE 3.

Environmental Cryptosporidium spp. prevalence reported in Tunisia.

Positive samples/samples examined
District Plants Raw wastewater Treated wastewater Sludge Technique Target gene Species identified

Cryptosporidium

oocyst/L

Genotype/subtype Reference
Tunis 5/6 6/7 0/8 1/5

PCR – RFLP

gp6

SSU rRNA

C. parvum

C. hominis

C. muris

C. andersoni

1–21

C. hominis

IaA27R3

IdA15G1

C. parvum

IIaA21R1

IIcA5G3

(Khouja et al. 2010)
Nationwide 16/18 42/110 8/110 5/12 PCR gp60

SSU rRNA

C. parvum

C. muris

C. andersoni

C. hominis

C. ubiquitum

rat genotype,

unknown Cryptosporidium,

C. meleagridis, and avian genotype II (C. ornithophilous)

NR

C. hominis

Ia, Id

C. parvum

IIa, IIc

(Ayed et al. 2012)

Abbreviation: NR: not reported.

3. Results

3.1. Cryptosporidium spp. Infections in Humans

Ten surveys were conducted to investigate the epidemiology of Cryptosporidium spp. infection in humans in Tunisia (Table 1, Figure 2).

FIGURE 2.

FIGURE 2

Map of Tunisia highlighting the main regions where Cryptosporidium spp. were detected (QGIS).

In all the studies, the target population was either adult patients with health issues (HIV, myeloma and colorectal cancers) and/or children less than 5 years old with either diarrhoea or an immune‐compromised system (Essid et al. 2008; Kourda et al. 2008; Cheikhrouhou et al. 2009; Essid et al. 2018). The infection prevalence varied from 0.05% to 20% with a higher prevalence in immuno‐compromised children. A range of clinical manifestations was observed for both asymptomatic and symptomatic patients. Symptoms included diarrhoea, abdominal pain, vomiting, anorexia, and weight loss.

Cryptosporidium species identified included C. parvum, C. hominis, and C. meleagridis. Among the ten studies reviewed, only three conducted subtype characterisations of the identified species (Essid et al. 2017, Essid et al. 2018; Rahmouni et al. 2014). Analysis of the gp60 glycoprotein revealed the presence of two C. parvum subtype families: IIa and IId. The IIaA16G2R1 subtype, which is commonly reported worldwide in both calves and humans, underscores the potential zoonotic role of calves as reservoirs. In this review, it was identified in two studies involving patients from both rural and urban areas (Essid et al. 2018; Rahmouni et al. 2014).

Only one subtype was identified for both C. hominis and C. meleagridis, IaA26G1R1 and IIIbA26G1R1 respectively (Essid et al. 2018; Essid et al. 2017).

Most studies investigating the epidemiology of Cryptosporidium spp. infection in humans have focused primarily on clinical aspects, such as symptoms, diagnostic methods, and the relationship between immunosuppression and clinical manifestations. However, risk factors and patterns of contamination have not been thoroughly examined.

3.2. Cryptosporidium spp. Infections in Animals

3.2.1. Cattle

Only two studies investigated the presence of Cryptosporidium spp. in calves (Soltane et al. 2007a; Rahmouni et al. 2014). The first study was a longitudinal survey aimed at determining the prevalence of Cryptosporidium spp. infection on a dairy farm in the Sfax region (Soltane et al. 2007a). A total of 480 fecal samples were collected from 30 calves under 1 month of age. All samples were analysed for Cryptosporidium spp. oocysts using microscopic examination of smears stained by the modified Ziehl‐Neelsen (MZN) technique. The parasite was detected in 26 calves (86.7%). Molecular characterisation revealed that the isolates were C. parvum, although genotyping was not performed. This study was the first to identify C. parvum in calves in Tunisia.

The second investigation aimed to study the diversity of the glycoprotein 60 in C. parvum in both humans and cattle in two rural regions of Northern Tunisia. Among seventy fecal samples from pre‐weaned calves, 15 were shown to be positive by the MZN method. Cryptosporidium parvum was the only species identified. Genotype analysis revealed that IIaA15G2R1 and IIdA16G1 were the predominant subtypes (Rahmouni et al. 2014) (Table 2, Figure 2).

3.2.2. Sheep and Goats

Cryptosporidium spp. were first detected in sheep from the Sidi Bouzid and Medenine districts. Ten fecal samples from 89 sheep yielded a positive result (25.2%), which were not genotyped. The infected sheep were apparently healthy at the moment of sampling. The infection prevalence was higher in lambs under 3 months (16.7%; 5/30 samples) compared to older sheep (8.5%; 5/59 samples) (Soltane et al. 2007b).

3.2.3. Poultry

Over 250 chicken and turkey fecal samples were examined by MZN. Of the 200 chicken samples examined only 9 were observed to be positive for Cryptosporidium spp. by MZN staining (Soltane et al. 2007b). The parasite was not detected in turkeys.

3.2.4. Camels

One study investigated the contamination of camels by Cryptosporidium spp. 110 healthy dromedaries aged between 3 to 8 months were sampled from the Ben Guerdan district. Fecal samples were examined by MZN stained and no parasites were observed (Soltane et al. 2007b).

Cryptosporidium spp. were not detected in horses aged between 1 to 3 years (n = 190) and in rabbits (n = 178) aged between 3 and 8 months using the MZN staining technique (Soltane et al. 2007b).

3.3. Cryptosporidium spp. Infections in the Environment

Two studies investigated the presence of Cryptosporidium spp. in wastewater and sludge samples from different sewage treatment plants located throughout Tunisia (Khouja et al. 2010; Ayed et al. 2012) (Table 3).

According to Khouja et al. (2010), of the 20 samples collected from six sewage treatment plants, Cryptosporidium spp. oocysts were detected in raw wastewater (5/7 samples), treated wastewater (1/8 samples) and sludge samples (4/5 samples). The contamination level was estimated by immunofluorescent microscopy and ranged between 1 and 21 oocysts/L. The contamination level was highest in raw wastewater.

In 2012, Ayed et al. (2012) evaluated the occurrence and geographical distribution of several zoonotic parasites including, Cryptosporidium spp., in raw wastewater (n = 110), treated wastewater (n = 110) and sludge (n = 12) collected monthly between 2005 and 2008 from 18 wastewater treatment plants. The results of the survey recorded a high prevalence and genetic diversity of pathogenic protists in treated and raw wastewater in Tunisia, including Cryptosporidium spp. Indeed, more than 6 Cryptosporidium species were detected with various subtypes. These findings suggest that the various sewage treatment processes adopted in Tunisia are insufficient in removing these parasites.

4. Discussion

Intestinal parasitic infections are of increasing importance worldwide, especially in developing countries. They affect both humans and animals and are highly resistant in the environment. Cryptosporidium spp., an intracellular protozoan parasite, have been recognised as an important cause of moderate to severe diarrhoea in children less than 5 years old (Kotloff et al. 2019a; Platts‐Mills et al. 2018). However, the potential economic impact and welfare implications of Cryptosporidium spp. infection remain poorly documented in North African.

This review provides a valuable summary of the occurrence of Cryptosporidium spp. in humans, animals and the environment in Tunisia. Based on published studies, C. parvum, C. hominis, and C. meleagridis are the species identified as being responsible for human cryptosporidiosis in Tunisia. Reported infection prevalence ranged from 0.09% (4/403 samples) for C. parvum in children under five years of age to 20% (3/15 samples) in patients with colorectal cancer. Cryptosporidium parvum was identified in four out of five studies, while C. hominis and C. meleagridis were detected in three of five studies, indicating similar frequencies. These findings are similar to the known distribution of Cryptosporidium species in Europe, where C. parvum and C. hominis are the most commonly reported species in humans (Chalmers et al. 2005; Leoni et al. 2006; Xiao 2010). This is notable, as both species are frequently associated with waterborne and foodborne outbreaks of human cryptosporidiosis (Xiao and Feng 2008).

Interestingly, C. meleagridis appears to be as prevalent as C. hominis in children from urban areas of Tunisia. A similar pattern has been reported in other regions of the world, such as Bangkok, where zoonotic species were found to be as prevalent as anthroponotic ones among HIV‐infected patients (Gatei et al. 2002). However, in the Tunisian context, these findings remain inconsistent and inconclusive, highlighting the need for further research to assess species‐specific infection risks, especially given that transmission routes (zoonotic vs. anthroponotic) vary between species.

All the reviewed studies targeted either healthy children or individuals with cancer or immunodeficiency and were mostly conducted in hospitals. The focus in these areas underscores the significant importance of Cryptosporidium spp. as a serious threat in vulnerable populations, emphasising the need for enhanced surveillance systems to improve early detection and response.

Molecular characterisation of Cryptosporidium species and subtypes plays a crucial role in identifying infection sources, particularly during outbreaks, and is essential for developing control and prevention strategies (Fan et al. 2019; Yang et al. 2021). In Tunisia, species identification and genotyping were conducted in some studies focusing on human infection. Molecular analysis of C. hominis at the subtype level, based on gp60 gene polymorphism, revealed that all isolates belonged to a single subtype family (Ia), with IaA26G1R1 being predominant. The detection of a single subtype family across different individuals suggests endemic transmission and highlights the role of anthroponotic transmission. Moreover, the consistent presence of the IaA26G1R1 subtype among HIV‐infected patients attending the same hospital suggests a possible nosocomial transmission (Vincent et al. 2009; Weber and Rutala 2001). This transmission route is well‐documented in intensive care units for various bacterial and fungal pathogens (Lemiech‐Mirowska et al. 2021). More recently, increasing attention has been given to the role of parasitic organisms, including Cryptosporidium spp., in nosocomial infections (Kosik‐Bogacka et al. 2024; Fürnkranz and Walochnik 2021; Brunet et al. 2016).

The data available from Tunisia regarding cryptosporidiosis in humans are valuable but incomplete making an in depth understanding of Cryptosporidium spp. transmission dynamics in the different regions of the country difficult.

Only three studies have assessed the prevalence of Cryptosporidium spp. infections in farm animals in Tunisia. These studies primarily report infections in livestock but are subject to several limitations.

Firstly, the study population selected was not optimal, because most of the animals sampled were adults (over one year of age) and asymptomatic, factors associated with a lower probability of detecting oocysts. In contrast, two studies conducted by Soltane et al. (2007b) and Rahmouni et al. (2014) focused on younger animals, specifically calves and lambs under five months of age, and reported significantly higher infection prevalences of 86.7% and 11.2%, respectively. These findings are consistent with existing evidence indicating that Cryptosporidium spp. infections are more frequent in young animals and may be significantly underestimated when surveillance is restricted to adult livestock. Furthermore, the available studies did not target farms with known cryptosporidiosis or a history of cryptosporidiosis. Consequently, the published data do not accurately reflect the true prevalence of Cryptosporidium spp. in neonatal diarrhoea among farm animals in Tunisia, despite the well‐documented role of this parasite in such cases worldwide (Jang et al. 2021; Li et al. 2019; Mammeri et al. 2019). The lack of locally relevant epidemiological data hampers efforts to assess the pathogen's impact on farm animal health and hinders the implementation of appropriate evidence‐based control programs.

Secondly, in most studies, diagnosis relied on the morphological identification of oocysts in fecal samples using microscopy techniques, especially the modified Ziehl‐Neelsen technique. While this method is accessible and inexpensive, it lacks the sensitivity and specificity of molecular techniques, potentially leading to underestimation of the true prevalence and diversity of Cryptosporidium species (Chalmers et al. 2011; Omoruyi et al. 2014). In fact, C. parvum was the only species identified in the three studies conducted in livestock animals in Tunisia. Further studies are needed to confirm these results.

This diagnostic limitation not only hinders effective surveillance but also impairs understanding of the zoonotic potential of these infections. Given the close interaction between humans and farm animals in many rural and peri‐urban areas of Tunisia, there is a pressing need to adopt molecular tools for accurate species and subtype identification. Such developments would improve disease monitoring and help clarify the role of animal reservoirs in human cryptosporidiosis.

In contrast, Cryptosporidium spp. infections are better characterised in Algeria, a neighbouring country that shares a 1020 km border with Tunisia and where there is significant movement of livestock between the countries. Ouakli et al. (2018) reported a molecular prevalence of Cryptosporidium spp. infection up to 52.2% (240/460 samples) in cattle aged between 2 days and 18 months, sampled from 10 farms distributed across the country. Moreover, another study identified the circulating species and the zoonotic subtypes in C. parvum IIa and IId in 41 calves (Sahraoui et al. 2023).

In conclusion, the currently available data on Cryptosporidium spp. infection in animals from Tunisia cannot be considered representative of the national situation. Community‐based studies employing molecular tools and a well‐designed sampling strategy are needed to: (i) determine the prevalence of cryptosporidiosis in the context of neonatal diarrhoea across different farms; (ii) identify circulating Cryptosporidium species to better understand contamination routes and assess zoonotic risk; and (iii) establish robust epidemiological surveillance to monitor parasite circulation.

Only two studies reported the contamination of the environment by Cryptosporidium spp. Findings from the two studies indicate a significant prevalence and genetic diversity of Cryptosporidium spp. in wastewater samples from various sewage treatment plants in Tunisia. The assessment of environmental contamination by Cryptosporidium spp. oocysts is limited to wastewater, without sufficient consideration of other exposure pathways such as drinking or irrigation water. The results confirmed the presence of Cryptosporidium spp. at varying concentrations and notable genetic diversity. Considering the role of wastewater‐based epidemiology as an epidemiological tool for monitoring parasites (Puchades‐Colera et al. 2025), the implication of these findings is not fully developed. In fact, due to Tunisia's limited water resources, treated wastewater has increasingly been used as an alternative source for domestic, industrial, and agricultural purposes. By 2007, approximately 30% of treated wastewater was used to irrigate nearly 9000 hectares of farmland (Office Nationale d'Assainissement 2012). Consequently, the government has established maximum limits for various chemicals, bacteriological contaminants, and parasite eggs. However, these regulations do not include protozoa such as Cryptosporidium spp. and Giardia duodenalis, which are frequently responsible for waterborne diarrhoea outbreaks in many countries (Bourli et al. 2024; Watier‐Grillot et al. 2022; Chalmers et al. 2021).

Results from the studies on the environment, suggest that current wastewater treatment methods may be insufficient to effectively eliminate Cryptosporidium spp. oocysts, highlighting a possible public health concern related to wastewater reuse. However, the actual risk of exposure and transmission associated with this practice remains uncertain and has not been adequately quantified. A more rigorous evaluation of health risks to humans and animals would require: (i) systematic monitoring of Cryptosporidium spp. oocysts before and after wastewater treatment; (ii) analysis and quantitative assessment of Cryptosporidium spp. oocysts in drinking water; and (iii) species‐level identification to better understand contamination sources and transmission pathways.

5. Conclusions and Perspectives

This review compiles existing data on the occurrence of Cryptosporidium spp. infection in Tunisia, providing valuable insights while also highlighting several important gaps in our knowledge.

The currently data available from Tunisia remain insufficient to fully elucidate the real impact and the transmission dynamics of Cryptosporidium spp. in both animals and humans. There is a significant gap in understanding the role of Cryptosporidium spp. in neonatal diarrhoea in farm animals. Moreover, existing studies are restricted to geographical zones therefore limiting the ability to draw nationwide epidemiological conclusions.

Additional investigations across diverse regions are therefore necessary to obtain a more comprehensive understanding of the parasite's epidemiological distribution. Future research should prioritise: (i) expanded molecular studies to determine the prevalence of cryptosporidiosis in farm animals and to identify circulation species and subtypes; (ii) detailed assessment of human risk factors, particularly those related to lifestyle, occupational exposure, and hygiene practices; (iii) identification of transmission routes, especially in rural populations with frequent contact with livestock; and (iv) development of targeted prevention and control strategies in high‐risk settings.

Accordingly, robust epidemiological surveillance within a One Health framework is essential to accurately estimate infection prevalence and to develop effective, evidence‐based intervention strategies.

Author Contributions

Faten Bouaicha: conceptualisation, investigation, writing – original draft, methodology, writing – review & editing. Aurélie Chevillot: writing – original draft, writing – review & editing. Sihem El Hamdi: writing – original draft, writing – review & editing. Bruno Polack: writing – original draft, writing – review & editing, supervision. Maxime Delsart: writing – review & editing, validation, methodology. Karim Tarik Adjou: conceptualisation, writing – original draft, writing – review & editing, validation, methodology, supervision

Funding

The authors have nothing to report.

Ethics Statement

This research did not require an ethical approval.

Conflicts of Interest

The authors declare no conflicts of interest.

Acknowledgements

The authors gratefully acknowledge Prof. Andrew Ponter for his assistance in revising the English of the manuscript.

Data Availability Statement

Data sharing not applicable to this article as no datasets were generated or analysed during the current study.

References

  1. Ayed, L. B. , Yang W., Widmer G., Cama V., Ortega Y., and Xiao L.. 2012. “Survey and Genetic Characterization of Wastewater in Tunisia for Cryptosporidium spp., Giardia duodenalis, Enterocytozoon bieneusi, Cyclospora cayetanensis and Eimeria spp.” Journal of Water and Health 10: 431–444. 10.2166/WH.2012.204. [DOI] [PubMed] [Google Scholar]
  2. Ben Abda, I. , Essid R., Mellouli F., Aoun K., Bejaoui M., and Bouratbine A.. 2011. “ Cryptosporidium Infection in Patients With Major Histocompatibility Complex Class II Deficiency Syndrome in Tunisia: Description of Five Cases.” Archives De Pediatrie 18: 939–944. 10.1016/J.ARCPED.2011.06.015. [DOI] [PubMed] [Google Scholar]
  3. Bourli, P. , Eslahi A. V., Tzoraki O., and Karanis P.. 2024. “Waterborne Transmission of Protozoan Parasites: A Review of Worldwide Outbreaks – An Update 2017–2022.” Journal of Water and Health 21, no. 10: 1421–1447. 10.2166/wh.2023.094. [DOI] [PubMed] [Google Scholar]
  4. Brunet, J. , Lemoine J. P., Pesson B., et al. 2016. “Ruling out Nosocomial Transmission of Cryptosporidium in a Renal Transplantation Unit: Case Report.” BMC Infectious Diseases 16, no. 1: 363. 10.1186/S12879-016-1661-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chalmers, R. M. , Campbell B. M., Crouch N., Charlett A., and Davies A. P.. 2011. “Comparison of Diagnostic Sensitivity and Specificity of Seven Cryptosporidium Assays Used in the UK.” Journal of Medical Microbiology 60: 1598–1604. 10.1099/JMM.0.034181-0. [DOI] [PubMed] [Google Scholar]
  6. Chalmers, R. M. , Ferguson C., Cacciò S., et al. 2005. “Direct Comparison of Selected Methods for Genetic Categorisation of Cryptosporidium Parvum and Cryptosporidium Hominis Species.” International Journal for Parasitology 35, no. 4: 397–410. 10.1016/j.ijpara.2005.01.001. [DOI] [PubMed] [Google Scholar]
  7. Chalmers, R. M. , Simmonds L. P., Wood M., Luxford M., Miller R., and Johnston R.. 2021. “Occurrence of Cryptosporidium Oocysts in Leisure Pools in the UK, 2017, and Modelling of Oocyst Contamination Events.” Water 13, no. 11: 1503. 10.3390/w13111503. [DOI] [Google Scholar]
  8. Cheikhrouhou, F. , Trabelsi H., Sellami H., Makni F., and Ayadi A.. 2009. “Parasitoses Intestinales Dans la Région de Sfax (Sud Tunisien): Etude Rétrospective.” Revue Tunisienne d'Infectiologie 3, no. 2: 14–18. [Google Scholar]
  9. Delahoy, M. J. , Wodnik B., McAliley L., et al. 2018. “Pathogens Transmitted in Animal Feces in Low‐ and Middle‐Income Countries.” International Journal of Hygiene and Environmental Health 221: 661–676. 10.1016/J.IJHEH.2018.03.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Efstratiou, A. , Ongerth J. E., and Karanis P.. 2017. “Waterborne Transmission of Protozoan Parasites: Review of Worldwide Outbreaks – An Update 2011–2016.” Water Research 114: 14–22. 10.1016/J.WATRES.2017.01.036. [DOI] [PubMed] [Google Scholar]
  11. Essid, R. , Chelbi H., Siala E., Bensghair I., Menotti J., and Bouratbine A.. 2017. “Polymorphism Study of Cryptosporidium hominis gp60 Subtypes Circulating in Tunisia.” Microbial Pathogenesis 110: 298–303. 10.1016/J.MICPATH.2017.06.011. [DOI] [PubMed] [Google Scholar]
  12. Essid, R. , Menotti J., Hanen C., Aoun K., and Bouratbine A.. 2018. “Genetic Diversity of Cryptosporidium isolates From Human Populations in an Urban Area of Northern Tunisia.” Infection, Genetics and Evolution 58: 237–242. 10.1016/J.MEEGID.2018.01.004. [DOI] [PubMed] [Google Scholar]
  13. Essid, R. , Mousli M., Aoun K., et al. 2008. “Identification of Cryptosporidium Species Infecting Humans in Tunisia.” American Journal of Tropical Medicine and Hygiene 79, no. 5: 702–705. [PubMed] [Google Scholar]
  14. Fan, Y. , Feng Y., and Xiao L.. 2019. “Comparative Genomics: How Has It Advanced Our Knowledge of Cryptosporidiosis Epidemiology?” Parasitology Research 118: 3195–3204. 10.1007/S00436-019-06537-X. [DOI] [PubMed] [Google Scholar]
  15. Fathallah, A. , Saghrouni F., Madani B., Ben Rejeb N., and Ben Said M.. 2004. “La Cryptosporidiose Infantile dans la Région de Sousse, Tunisie [Infantile Cryptosporidiosis in Sousse Area, Tunisia].” Archives De Pediatrie 11, no. 3: 207–211. French. 10.1016/j.arcped.2003.11.011. [DOI] [PubMed] [Google Scholar]
  16. Fürnkranz, U. , and Walochnik J.. 2021. “Nosocomial Infections: Do Not Forget the Parasites!” Pathogens 10: 238. 10.3390/PATHOGENS10020238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gatei, W. , Suputtamongkol Y., Waywa D., et al. 2002. “Zoonotic Species of Cryptosporidium Are as Prevalent as the Anthroponotic in HIV‐infected Patients in Thailand.” Annals of Tropical Medicine and Parasitology 96, no. 8: 797–802. 10.1179/000349802125002202. [DOI] [PubMed] [Google Scholar]
  18. Hammami, I. , Amdouni Y., Romdhane R., et al. 2024. “Prevalence of Fasciola hepatica Infection in Slaughtered Sheep From Northwest Tunisia and Its Risk Factors: Association With Gastrointestinal Helminths Infection and Anaemia.” Veterinary Medicine and Science 10: e1575. 10.1002/vms3.1575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jang, D. H. , Cho H. C., Shin S. U., et al. 2021. “Prevalence and Distribution Pattern of Cryptosporidium spp. Among Pre‐Weaned Diarrheic Calves in the Republic of Korea.” PLoS ONE 16: e0259824. 10.1371/JOURNAL.PONE.0259824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jelassi, R. , Chelbi H., Certad G., et al. 2024. “[High Prevalence of Cryptosporidium Infection in Colorectal Cancer Cases From Tunisia].” Medecine Tropicale et Sante Internationale 4, no. 3. 10.48327/MTSI.V4I3.2024.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Khamassi Khbou, M. , Rouatbi M., Romdhane R., et al. 2021. “Tick Infestation and Piroplasm Infection in Barbarine and Queue Fine de l'Ouest Autochthonous Sheep Breeds in Tunisia, North Africa.” Animals (Basel) 11, no. 3:839. 10.3390/ani11030839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Khouja, L. B. A. , Cama V., and Xiao L.. 2010. “Parasitic Contamination in Wastewater and Sludge Samples in Tunisia Using Three Different Detection Techniques.” Parasitology Research 107: 109–116. 10.1007/S00436-010-1844-8. [DOI] [PubMed] [Google Scholar]
  23. Kosik‐Bogacka, D. , Łanocha‐Arendarczyk N., Korzeniewski K., et al. 2024. “ Cryptosporidium spp. Infection in Adult Kidney Transplant Patients: a Systematic Review and Meta‐Analysis.” Journal of Clinical Medicine 13, no. 21:6395. 10.3390/JCM13216395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kotloff, K. L. , Nasrin D., Blackwelder W. C., et al. 2019a. “The Incidence, Aetiology, and Adverse Clinical Consequences of Less Severe Diarrhoeal Episodes Among Infants and Children Residing in Low‐Income and Middle‐Income Countries: A 12‐Month Case‐Control Study as a Follow‐On to the Global Enteric Multicenter Study (GEMS).” The Lancet Global Health 7: e568–e584. 10.1016/S2214-109X(19)30076-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kotloff, K. L. , Nasrin D., Blackwelder W. C., et al. 2019b. “The Incidence, Aetiology, and Adverse Clinical Consequences of Less Severe Diarrhoeal Episodes Among Infants and Children Residing in Low‐Income and Middle‐Income Countries: A 12‐Month Case‐Control Study as a Follow‐On to the Global Enteric Multicenter Study (GEMS).” The Lancet Global Health 7: e568–e584. 10.1016/S2214-109X(19)30076-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kourda, N. , Blel A., Ben Jilani B., and Zermani R.. 2008. “Cryptosporidiose Gastrique Révélant un Carcinoma à Petites Cellules Bronchique (Tunisie).” Bulletin De La Societe De Pathologie Exotique 101, no. 1: 22–23. [PubMed] [Google Scholar]
  27. Lebbad, M. , Winiecka‐Krusnell J., Stensvold C. R., and Beser J.. 2021. “High Diversity of Cryptosporidium Species and Subtypes Identified in Cryptosporidiosis Acquired in Sweden and Abroad.” Pathogens 10: 523. 10.3390/PATHOGENS10050523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lemiech‐Mirowska, E. , Kiersnowska Z. M., Michałkiewicz M., Depta A., and Marczak M.. 2021. “Nosocomial Infections as One of the Most Important Problems of Healthcare System.” Annals of Agricultural and Environmental Medicine 28: 361–366. 10.26444/AAEM/122629. [DOI] [PubMed] [Google Scholar]
  29. Leoni, F. , Gallimore C. I., Green J., and McLauchlin J.. 2006. “Characterisation of Small Double Stranded RNA Molecule in Cryptosporidium Hominis, Cryptosporidium felis and Cryptosporidium Meleagridis.” Parasitology International 55, no. 4: 299–306. 10.1016/J.PARINT.2006.06.006. [DOI] [PubMed] [Google Scholar]
  30. Levine, M. M. , Nasrin D., Acácio S., et al. 2020. “Diarrhoeal Disease and Subsequent Risk of Death in Infants and Children Residing in Low‐Income and Middle‐Income Countries: Analysis of the GEMS Case‐Control Study and 12‐Month GEMS‐1A Follow‐On Study.” The Lancet Global Health 8: e204–e214. 10.1016/S2214-109X(19)30541-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Li, N. , Wang R., Cai M., Jiang W., Feng Y., and Xiao L.. 2019. “Outbreak of Cryptosporidiosis Due to Cryptosporidium parvum Subtype IIdA19G1 in Neonatal Calves on a Dairy Farm in China.” International Journal for Parasitology 49: 569. 10.1016/J.IJPARA.2019.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Mammeri, M. , Chevillot A., Chenafi I., et al. 2019. “Molecular Characterization of Cryptosporidium Isolates From Diarrheal Dairy Calves in France.” Veterinary Parasitology: Regional Studies and Reports 18: 100323. 10.1016/J.VPRSR.2019.100323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Office National d'Assainissement (ONAS) . 2012. Rapport Annuel D'exploitation Des Stations d’épurations de l'année 2006. Office National d'Assainissement, Tunis, Tunisia, 80. [Google Scholar]
  34. Omoruyi, B. E. , Nwodo U. U., Udem C. S., and Okonkwo F. O.. 2014. “Comparative Diagnostic Techniques for Cryptosporidium Infection.” Molecules 19: 2674. 10.3390/MOLECULES19022674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ouakli, N. , Belkhiri A., de Lucio A., et al. 2018. “ Cryptosporidium‐Associated Diarrhoea in Neonatal Calves in Algeria.” Veterinary Parasitology: Regional Studies and Reports 12: 78–84. 10.1016/j.vprsr.2018.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Platts‐Mills, J. A. , Liu J., Rogawski E. T., et al. 2018. “Use of Quantitative Molecular Diagnostic Methods to Assess the Aetiology, Burden, and Clinical Characteristics of Diarrhoea in Children in Low‐Resource Settings: A Reanalysis of the MAL‐ED Cohort Study.” The Lancet Global Health 6: e1309–e1318. 10.1016/S2214-109X(18)30349-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Puchades‐Colera, P. , Girón‐Guzmán I., Díaz‐Reolid A., Sánchez G., and Pérez‐Cataluña A.. 2025. “Wastewater‐Based Epidemiology for Waterborne Protozoa: A Comparison of Analytical Methods for Detecting Cryptosporidium spp.” Science of the Total Environment 987: 179789. 10.1016/j.scitotenv.2025.179789. [DOI] [PubMed] [Google Scholar]
  38. Rahmouni, I. , Essid R., Aoun K., and Bouratbine A.. 2014. “Glycoprotein 60 Diversity in Cryptosporidium parvum Causing Human and Cattle Cryptosporidiosis in the Rural Region of Northern Tunisia.” American Journal of Tropical Medicine and Hygiene 90: 346–350. 10.4269/AJTMH.13-0522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Rouatbi, M. , Romdhane R., Bouaicha F., et al. 2020. “Individual Variability Among Autochthonous Sheep in Northern Tunisia to Infection by Abomasum Nematodes and Babesia/Theileria Parasites.” Veterinary Medicine and Science 6, no. 4: 834–845. 10.1002/vms3.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Ryan, U. M. , Feng Y., Fayer R., and Xiao L.. 2021b. “Taxonomy and Molecular Epidemiology of Cryptosporidium and Giardia – A 50 Year Perspective (1971‐2021).” International Journal for Parasitology 51: 1099–1119. 10.1016/J.IJPARA.2021.08.007. [DOI] [PubMed] [Google Scholar]
  41. Ryan, U. , Zahedi A., Feng Y., and Xiao L.. 2021a. “An Update on Zoonotic Cryptosporidium Species and Genotypes in Humans.” Animals (Basel) 11, no. 11:3307. 10.3390/ani11113307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sahraoui, L. , Mammeri M., Thomas M., et al. 2023. “Identification des Familles de Sous‐Types Zoonotiques Cryptosporidium parvum IIa et IId et de Cryptosporidium bovis Chez les Veaux en Algérie.” Revue d'élevage Et De médecine vétérinaire Des Pays Tropicaux 76: 1–6. 10.19182/remvt.37159. [DOI] [Google Scholar]
  43. Soltane, R. , Guyot K., Dei‐Cas E., and Ayadi A.. 2007a. “ Cryptosporidium parvum (Eucoccidiorida: Cryptosporiidae) in Calves: Results of a Longitudinal Study in a Dairy Farm in Sfax, Tunisia.” Parasite 14: 309–312. 10.1051/PARASITE/2007144309. [DOI] [PubMed] [Google Scholar]
  44. Soltane, R. , Guyot K., Dei‐Cas E., and Ayadi A.. 2007b. “Prevalence of Cryptosporidium spp. (Eucoccidiorida: Cryptosporiidae) in Seven Species of Farm Animals in Tunisia.” Parasite 14: 335–338. 10.1051/PARASITE/2007144335. [DOI] [PubMed] [Google Scholar]
  45. Sow, S. O. , Muhsen K., Nasrin D., et al. 2016. “The Burden of Cryptosporidium Diarrheal Disease Among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub‐Saharan Africa and South Asia, Utilizing Data From the Global Enteric Multicenter Study (GEMS).” PLOS Neglected Tropical Diseases 10, no. 5: e0004729. 10.1371/JOURNAL.PNTD.0004729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sponseller, J. K. , Griffiths J. K., and Tzipori S.. 2014. “The Evolution of Respiratory Cryptosporidiosis: Evidence for Transmission by Inhalation.” Clinical Microbiology Reviews 27, no. 3: 575–586. 10.1128/CMR.00115-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Vincent, J. L. , Rello J., Marshall J., et al. 2009. “International Study of the Prevalence and Outcomes of Infection in Intensive Care Units.” Jama 302: 2323–2329. 10.1001/JAMA.2009.1754. [DOI] [PubMed] [Google Scholar]
  48. Watier‐Grillot, S. , Costa D., Petit C., et al. 2022. “Cryptosporidiosis Outbreaks Linked to the Public Water Supply in a Military camp, France.” PLOS Neglected Tropical Diseases 16, no. 9: e0010776. 10.1371/journal.pntd.0010776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Weber, D. J. , and Rutala W. A.. 2001. “The Emerging Nosocomial Pathogens Cryptosporidium, Escherichia coli 0157: H7, Helicobacter pylori, and Hepatitis C: Epidemiology, Environmental Survival, Efficacy of Disinfection, and Control Measures.” Infection Control and Hospital Epidemiology 22: 306–315. 10.1086/501907. [DOI] [PubMed] [Google Scholar]
  50. Xiao, L. 2010. “Molecular Epidemiology of Cryptosporidiosis: an Update.” Experimental Parasitology 124, no. 1: 80–89. 10.1016/J.EXPPARA.2009.03.018. [DOI] [PubMed] [Google Scholar]
  51. Xiao, L. , and Feng Y.. 2008. “Zoonotic Cryptosporidiosis.” FEMS Immunology and Medical Microbiology 52, no. 3: 309–323. 10.1111/J.1574-695X.2008.00377.X. [DOI] [PubMed] [Google Scholar]
  52. Yang, X. , Guo Y., Xiao L., and Feng Y.. 2021. “Molecular Epidemiology of Human Cryptosporidiosis in Low‐ and Middle‐Income Countries.” Clinical Microbiology Reviews 34: 1–26. 10.1128/CMR.00087-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Zahedi, A. , and Ryan U.. 2020. “ Cryptosporidium – An Update With an Emphasis on Foodborne and Waterborne Transmission.” Research in Veterinary Science 132: 500–512. 10.1016/J.RVSC.2020.08.002. [DOI] [PubMed] [Google Scholar]
  54. Zhao, L. , Chai H. L., Wang M. Y., et al. 2023. “Prevalence and Molecular Characterization of Cryptosporidium spp. in Dairy Cattle in Central Inner Mongolia, Northern China.” BMC Veterinary Research 19: 1–11. 10.1186/S12917-023-03696-Z/FIGURES/1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data sharing not applicable to this article as no datasets were generated or analysed during the current study.


Articles from Veterinary Medicine and Science are provided here courtesy of Wiley

RESOURCES